Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969370010> ?p ?o ?g. }
- W2969370010 endingPage "1774" @default.
- W2969370010 startingPage "1765" @default.
- W2969370010 abstract "Purpose: Pediatric craniopharyngioma, adult base-of-skull sarcoma and chordoma cases are all regarded as priority candidates for proton therapy. In this study, a dosimetric comparison between volumetric modulated arc therapy (VMAT) and intensity modulated proton therapy (IMPT) was first performed. We then investigated the impact of physical and biological uncertainties. We assessed whether IMPT plans remained dosimetrically superior when such uncertainty estimates were considered, especially with regards to sparing organs at risk (OARs).Methodology: We studied 10 cases: four chondrosarcoma, two chordoma and four pediatric craniopharyngioma. VMAT and IMPT plans were created according to modality-specific protocols. For IMPT, we considered (i) variable RBE modeling using the McNamara model for different values of (α/β)x, and (ii) robustness analysis with ±3 mm set-up and 3.5% range uncertainties.Results: When comparing the VMAT and IMPT plans, the dosimetric advantages of IMPT were clear: IMPT led to reduced integral dose and, typically, improved CTV coverage given our OAR constraints. When physical robustness analysis was performed for IMPT, some uncertainty scenarios worsened the CTV coverage but not usually beyond that achieved by VMAT. Certain scenarios caused OAR constraints to be exceeded, particularly for the brainstem and optical chiasm. However, variable RBE modeling predicted even more substantial hotspots, especially for low values of (α/β)x. Variable RBE modeling often prompted dose constraints to be exceeded for critical structures.Conclusion: For base-of-skull and pediatric craniopharyngioma cases, both physical and biological robustness analyses should be considered for IMPT: these analyses can substantially affect the sparing of OARs and comparisons against VMAT. All proton RBE modeling is subject to high levels of uncertainty, but the clinical community should remain cognizant possible RBE effects. Careful clinical and imaging follow-up, plus further research on end-of-range RBE mitigation strategies such as LET optimization, should be prioritized for these cohorts of proton patients." @default.
- W2969370010 created "2019-08-29" @default.
- W2969370010 creator A5003179492 @default.
- W2969370010 creator A5008943001 @default.
- W2969370010 creator A5009340886 @default.
- W2969370010 creator A5014220089 @default.
- W2969370010 creator A5015322350 @default.
- W2969370010 creator A5022052810 @default.
- W2969370010 creator A5048607875 @default.
- W2969370010 creator A5061063908 @default.
- W2969370010 creator A5075044952 @default.
- W2969370010 creator A5083786046 @default.
- W2969370010 creator A5088149497 @default.
- W2969370010 date "2019-08-20" @default.
- W2969370010 modified "2023-10-18" @default.
- W2969370010 title "The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT" @default.
- W2969370010 cites W1995087795 @default.
- W2969370010 cites W1999189079 @default.
- W2969370010 cites W2004227663 @default.
- W2969370010 cites W2005775826 @default.
- W2969370010 cites W2012942336 @default.
- W2969370010 cites W2015323651 @default.
- W2969370010 cites W2018595195 @default.
- W2969370010 cites W2027131948 @default.
- W2969370010 cites W2029765949 @default.
- W2969370010 cites W2029775895 @default.
- W2969370010 cites W2040992522 @default.
- W2969370010 cites W2055233491 @default.
- W2969370010 cites W2060625002 @default.
- W2969370010 cites W2077331155 @default.
- W2969370010 cites W2083770395 @default.
- W2969370010 cites W2102192086 @default.
- W2969370010 cites W2104133157 @default.
- W2969370010 cites W2104484857 @default.
- W2969370010 cites W2130878651 @default.
- W2969370010 cites W2134187229 @default.
- W2969370010 cites W2138289701 @default.
- W2969370010 cites W2150090970 @default.
- W2969370010 cites W2153351327 @default.
- W2969370010 cites W2155976688 @default.
- W2969370010 cites W2156760977 @default.
- W2969370010 cites W2169056774 @default.
- W2969370010 cites W2210992767 @default.
- W2969370010 cites W2266637648 @default.
- W2969370010 cites W2268644431 @default.
- W2969370010 cites W2287874371 @default.
- W2969370010 cites W2293429046 @default.
- W2969370010 cites W2299288972 @default.
- W2969370010 cites W2318901295 @default.
- W2969370010 cites W2335821915 @default.
- W2969370010 cites W2335837419 @default.
- W2969370010 cites W2339538311 @default.
- W2969370010 cites W2406988819 @default.
- W2969370010 cites W2513819086 @default.
- W2969370010 cites W2529814419 @default.
- W2969370010 cites W2572695447 @default.
- W2969370010 cites W2573746316 @default.
- W2969370010 cites W2592540965 @default.
- W2969370010 cites W2764174300 @default.
- W2969370010 cites W2765271641 @default.
- W2969370010 cites W2783885972 @default.
- W2969370010 cites W2791108487 @default.
- W2969370010 cites W2802172296 @default.
- W2969370010 cites W2804715948 @default.
- W2969370010 cites W2806116757 @default.
- W2969370010 cites W2812370231 @default.
- W2969370010 cites W2885829702 @default.
- W2969370010 cites W2904195639 @default.
- W2969370010 cites W2905391434 @default.
- W2969370010 cites W2938584164 @default.
- W2969370010 doi "https://doi.org/10.1080/0284186x.2019.1653496" @default.
- W2969370010 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6882303" @default.
- W2969370010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31429359" @default.
- W2969370010 hasPublicationYear "2019" @default.
- W2969370010 type Work @default.
- W2969370010 sameAs 2969370010 @default.
- W2969370010 citedByCount "11" @default.
- W2969370010 countsByYear W29693700102020 @default.
- W2969370010 countsByYear W29693700102021 @default.
- W2969370010 countsByYear W29693700102022 @default.
- W2969370010 countsByYear W29693700102023 @default.
- W2969370010 crossrefType "journal-article" @default.
- W2969370010 hasAuthorship W2969370010A5003179492 @default.
- W2969370010 hasAuthorship W2969370010A5008943001 @default.
- W2969370010 hasAuthorship W2969370010A5009340886 @default.
- W2969370010 hasAuthorship W2969370010A5014220089 @default.
- W2969370010 hasAuthorship W2969370010A5015322350 @default.
- W2969370010 hasAuthorship W2969370010A5022052810 @default.
- W2969370010 hasAuthorship W2969370010A5048607875 @default.
- W2969370010 hasAuthorship W2969370010A5061063908 @default.
- W2969370010 hasAuthorship W2969370010A5075044952 @default.
- W2969370010 hasAuthorship W2969370010A5083786046 @default.
- W2969370010 hasAuthorship W2969370010A5088149497 @default.
- W2969370010 hasBestOaLocation W29693700101 @default.
- W2969370010 hasConcept C126838900 @default.
- W2969370010 hasConcept C141071460 @default.
- W2969370010 hasConcept C2776112939 @default.
- W2969370010 hasConcept C2777047896 @default.